S&P 500   4,543.86 (-0.13%)
DOW   35,662.62 (+0.17%)
QQQ   375.70 (-0.42%)
AAPL   149.55 (+0.05%)
MSFT   310.07 (-0.22%)
FB   324.07 (-5.21%)
GOOGL   2,757.00 (-2.84%)
TSLA   907.32 (+1.49%)
AMZN   3,383.30 (-1.51%)
NVDA   229.73 (+1.24%)
BABA   179.54 (+1.19%)
NIO   39.74 (-0.58%)
CGC   13.59 (-3.21%)
GE   104.43 (+1.24%)
AMD   120.11 (+0.65%)
MU   67.84 (-1.17%)
T   25.63 (-0.50%)
F   16.41 (-0.85%)
ACB   7.20 (-2.31%)
DIS   169.81 (-0.89%)
PFE   42.80 (-0.14%)
BA   215.12 (+0.36%)
AMC   36.75 (-6.35%)
S&P 500   4,543.86 (-0.13%)
DOW   35,662.62 (+0.17%)
QQQ   375.70 (-0.42%)
AAPL   149.55 (+0.05%)
MSFT   310.07 (-0.22%)
FB   324.07 (-5.21%)
GOOGL   2,757.00 (-2.84%)
TSLA   907.32 (+1.49%)
AMZN   3,383.30 (-1.51%)
NVDA   229.73 (+1.24%)
BABA   179.54 (+1.19%)
NIO   39.74 (-0.58%)
CGC   13.59 (-3.21%)
GE   104.43 (+1.24%)
AMD   120.11 (+0.65%)
MU   67.84 (-1.17%)
T   25.63 (-0.50%)
F   16.41 (-0.85%)
ACB   7.20 (-2.31%)
DIS   169.81 (-0.89%)
PFE   42.80 (-0.14%)
BA   215.12 (+0.36%)
AMC   36.75 (-6.35%)
S&P 500   4,543.86 (-0.13%)
DOW   35,662.62 (+0.17%)
QQQ   375.70 (-0.42%)
AAPL   149.55 (+0.05%)
MSFT   310.07 (-0.22%)
FB   324.07 (-5.21%)
GOOGL   2,757.00 (-2.84%)
TSLA   907.32 (+1.49%)
AMZN   3,383.30 (-1.51%)
NVDA   229.73 (+1.24%)
BABA   179.54 (+1.19%)
NIO   39.74 (-0.58%)
CGC   13.59 (-3.21%)
GE   104.43 (+1.24%)
AMD   120.11 (+0.65%)
MU   67.84 (-1.17%)
T   25.63 (-0.50%)
F   16.41 (-0.85%)
ACB   7.20 (-2.31%)
DIS   169.81 (-0.89%)
PFE   42.80 (-0.14%)
BA   215.12 (+0.36%)
AMC   36.75 (-6.35%)
S&P 500   4,543.86 (-0.13%)
DOW   35,662.62 (+0.17%)
QQQ   375.70 (-0.42%)
AAPL   149.55 (+0.05%)
MSFT   310.07 (-0.22%)
FB   324.07 (-5.21%)
GOOGL   2,757.00 (-2.84%)
TSLA   907.32 (+1.49%)
AMZN   3,383.30 (-1.51%)
NVDA   229.73 (+1.24%)
BABA   179.54 (+1.19%)
NIO   39.74 (-0.58%)
CGC   13.59 (-3.21%)
GE   104.43 (+1.24%)
AMD   120.11 (+0.65%)
MU   67.84 (-1.17%)
T   25.63 (-0.50%)
F   16.41 (-0.85%)
ACB   7.20 (-2.31%)
DIS   169.81 (-0.89%)
PFE   42.80 (-0.14%)
BA   215.12 (+0.36%)
AMC   36.75 (-6.35%)
NYSE:PHG

Koninklijke Philips Stock Forecast, Price & News

$48.04
+0.54 (+1.14 %)
(As of 10/22/2021 11:04 AM ET)
Add
Compare
Today's Range
$47.86
$48.18
50-Day Range
$43.03
$48.55
52-Week Range
$42.47
$61.23
Volume16,362 shs
Average Volume787,284 shs
Market Capitalization$43.49 billion
P/E Ratio36.39
Dividend Yield1.89%
Beta0.8
30 days | 90 days | 365 days | Advanced Chart
Receive PHG News and Ratings via Email

Sign-up to receive the latest news and ratings for Koninklijke Philips and its competitors with MarketBeat's FREE daily newsletter.


Koninklijke Philips logo

About Koninklijke Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Re

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
X-ray apparatus & tubes
Sub-Industry
N/A
Sector
Medical
Employees
81,592
Year Founded
N/A

Sales & Book Value

Annual Sales
$22.31 billion
Cash Flow
$4.47 per share
Book Value
$15.02 per share

Profitability

Net Income
$1.36 billion

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$43.49 billion
Next Earnings Date
1/24/2022 (Estimated)
Optionable
Optionable

MarketRank

Overall MarketRank

1.30 out of 5 stars

Medical Sector

1127th out of 1,358 stocks

X-Ray Apparatus & Tubes Industry

5th out of 6 stocks

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Koninklijke Philips (NYSE:PHG) Frequently Asked Questions

Is Koninklijke Philips a buy right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Koninklijke Philips in the last year. There are currently 5 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Koninklijke Philips stock.
View analyst ratings for Koninklijke Philips
or view top-rated stocks.

What stocks does MarketBeat like better than Koninklijke Philips?

Wall Street analysts have given Koninklijke Philips a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Koninklijke Philips wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Koninklijke Philips?

Koninklijke Philips saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 1,090,000 shares, an increase of 43.0% from the September 15th total of 762,300 shares. Based on an average daily volume of 1,120,000 shares, the days-to-cover ratio is currently 1.0 days. Currently, 0.1% of the shares of the company are short sold.
View Koninklijke Philips' Short Interest
.

When is Koninklijke Philips' next earnings date?

Koninklijke Philips is scheduled to release its next quarterly earnings announcement on Monday, January 24th 2022.
View our earnings forecast for Koninklijke Philips
.

How were Koninklijke Philips' earnings last quarter?

Koninklijke Philips (NYSE:PHG) released its quarterly earnings data on Sunday, October, 17th. The technology company reported $0.47 EPS for the quarter, missing the consensus estimate of $0.57 by $0.10. The technology company had revenue of $4.16 billion for the quarter, compared to analyst estimates of $4.21 billion. Koninklijke Philips had a trailing twelve-month return on equity of 15.15% and a net margin of 5.48%. The firm's quarterly revenue was down 5.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.60 EPS.
View Koninklijke Philips' earnings history
.

How has Koninklijke Philips' stock been impacted by COVID-19 (Coronavirus)?

Koninklijke Philips' stock was trading at $37.56 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PHG shares have increased by 26.5% and is now trading at $47.50.
View which stocks have been most impacted by COVID-19
.

How often does Koninklijke Philips pay dividends? What is the dividend yield for Koninklijke Philips?

Koninklijke Philips declared an annual dividend on Wednesday, January 27th. Stockholders of record on Tuesday, May 11th will be paid a dividend of $1.0331 per share on Wednesday, June 9th. This represents a dividend yield of 1.6%. The ex-dividend date is Monday, May 10th. This is a positive change from Koninklijke Philips's previous annual dividend of $0.96.
View Koninklijke Philips' dividend history
.

Is Koninklijke Philips a good dividend stock?

Koninklijke Philips pays an annual dividend of $0.88 per share and currently has a dividend yield of 1.89%. Koninklijke Philips has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Koninklijke Philips is 38.94%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Koninklijke Philips will have a dividend payout ratio of 35.77% next year. This indicates that Koninklijke Philips will be able to sustain or increase its dividend.
View Koninklijke Philips' dividend history.

Who are Koninklijke Philips' key executives?

Koninklijke Philips' management team includes the following people:
  • Frans van Houten, Chief Executive Officer
  • Sophie Bechu, Chief Operating Officer & Executive Vice President
  • Abhijit Bhattacharya, Chief Financial Officer & Executive Vice President
  • Jan Kimpen, Chief Medical Officer
  • Bert van Meurs, Chief Business Leader-Image Guided Therapy & EVP

What is Vitor Rocha's approval rating as Koninklijke Philips' CEO?

209 employees have rated Koninklijke Philips CEO Vitor Rocha on Glassdoor.com. Vitor Rocha has an approval rating of 90% among Koninklijke Philips' employees.

Who are some of Koninklijke Philips' key competitors?

What other stocks do shareholders of Koninklijke Philips own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Koninklijke Philips investors own include Cisco Systems (CSCO), Raytheon Technologies (RTX), General Electric (GE), NVIDIA (NVDA), Advanced Micro Devices (AMD), Bank of America (BAC), Micron Technology (MU), QUALCOMM (QCOM), Ingles Markets (IMKTA) and AT&T (T).

What is Koninklijke Philips' stock symbol?

Koninklijke Philips trades on the New York Stock Exchange (NYSE) under the ticker symbol "PHG."

Who are Koninklijke Philips' major shareholders?

Koninklijke Philips' stock is owned by many different retail and institutional investors. Top institutional investors include Manning & Napier Group LLC (0.01%), Capital Insight Partners LLC (0.00%), Private Advisor Group LLC (0.00%), Becker Capital Management Inc. (0.00%), Gofen & Glossberg LLC IL (0.00%) and KCS Wealth Advisory (0.00%).
View institutional ownership trends for Koninklijke Philips
.

Which major investors are selling Koninklijke Philips stock?

PHG stock was sold by a variety of institutional investors in the last quarter, including Stonnington Group LLC, Raymond James Trust N.A., 44 Wealth Management LLC, Ritholtz Wealth Management, Gofen & Glossberg LLC IL, Park National Corp OH, Kestra Advisory Services LLC, and Kestra Private Wealth Services LLC.
View insider buying and selling activity for Koninklijke Philips
or view top insider-selling stocks.

Which major investors are buying Koninklijke Philips stock?

PHG stock was purchased by a variety of institutional investors in the last quarter, including Becker Capital Management Inc., Private Advisor Group LLC, FNY Investment Advisers LLC, Capital Insight Partners LLC, Altfest L J & Co. Inc., Lester Murray Antman dba SimplyRich, Veriti Management LLC, and Green Alpha Advisors LLC.
View insider buying and selling activity for Koninklijke Philips
or or view top insider-buying stocks.

How do I buy shares of Koninklijke Philips?

Shares of PHG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Koninklijke Philips' stock price today?

One share of PHG stock can currently be purchased for approximately $47.50.

How much money does Koninklijke Philips make?

Koninklijke Philips has a market capitalization of $43.00 billion and generates $22.31 billion in revenue each year. The technology company earns $1.36 billion in net income (profit) each year or $2.26 on an earnings per share basis.

How many employees does Koninklijke Philips have?

Koninklijke Philips employs 81,592 workers across the globe.

What is Koninklijke Philips' official website?

The official website for Koninklijke Philips is www.philips.com.

Where are Koninklijke Philips' headquarters?

Koninklijke Philips is headquartered at PHILIPS CENTER AMSTELPLEIN 2, AMSTERDAM P7, 1096 BC.

How can I contact Koninklijke Philips?

Koninklijke Philips' mailing address is PHILIPS CENTER AMSTELPLEIN 2, AMSTERDAM P7, 1096 BC. The technology company can be reached via phone at (120) 597-7777 or via email at [email protected].


This page was last updated on 10/22/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.